Trace Genomics
Media and Information Services (B2B)
Trace Genomics valuation and funding history | Last updated: December 14, 2018 | 1 funding rounds
Current Valuation
N/A
As of December 14, 2018
Total Funding Raised
N/A
Across 1 round
Last Round
Early Stage VC (Series A)
$19.7M
Last Funding
Dec 2018
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| December 14, 2018 | Early Stage VC (Series A) | $19.7M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Trace Genomics is currently valued at N/A as of December 14, 2018.
What is Trace Genomics Worth in 2026?
Trace Genomics is a leading private company in the Media and Information Services (B2B) sector. Track Trace Genomics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Trace Genomics Valuation is Determined
Private company valuations like Trace Genomics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.